The abnormalities of PI3K/AKT signaling pathway and its roles in aberrant signaling cascades in human cancers have been validated, such as lung cancer, breast cancer, prostate cancer, colon cancer, gastric cancer and so on [39]. This evidence concerns the gene AKT1 and lung cancer.